SEC Form 4 · accession 0000914190-26-000139
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert V Baumgartner
Director
Period of report
Sep 22, 2026
Accepted (ET)
Sep 24, 2026 · 4:52 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 22, 2026 | M | 15,940 | $0.00 | A | 62,443 | D | |
| Common Stock | Sep 22, 2026 | F | 5,559 | $72.55 | D | 56,884 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $25.30 | Sep 22, 2026 | M | 15,940 | D | Oct 26, 2017 | Oct 26, 2026 | Common Stock | 15,940 | 0 | D |
| Stock Options (Right to Buy) | $31.26 | holding | — | — | — | Oct 25, 2018 | Oct 26, 2027 | Common Stock | 12,500 | 12,500 | D |
| Stock Options (Right to Buy) | $44.96 | holding | — | — | — | Oct 24, 2019 | Oct 25, 2028 | Common Stock | 7,592 | 7,592 | D |
| Stock Options (Right to Buy) | $50.41 | holding | — | — | — | Oct 24, 2020 | Oct 24, 2029 | Common Stock | 8,044 | 8,044 | D |
| Stock Options (Right to Buy) | $63.92 | holding | — | — | — | Oct 28, 2021 | Oct 29, 2030 | Common Stock | 6,028 | 6,028 | D |
| Stock Options (Right to Buy) | $128.81 | holding | — | — | — | Oct 27, 2022 | Oct 28, 2031 | Common Stock | 2,532 | 2,532 | D |
| Stock Options (Right to Buy) | $73.94 | holding | — | — | — | Oct 26, 2023 | Oct 27, 2032 | Common Stock | 3,460 | 3,460 | D |
| Stock Options (Right to Buy) | $61.51 | holding | — | — | — | Oct 24, 2024 | Oct 26, 2033 | Common Stock | 3,937 | 3,937 | D |
| Stock Options (Right to Buy) | $68.37 | holding | — | — | — | Oct 24, 2025 | Oct 24, 2034 | Common Stock | 3,511 | 3,511 | D |
| Stock Options (Right to Buy)F1 | $60.96 | holding | — | — | — | — | Oct 30, 2035 | Common Stock | 3,777 | 3,777 | D |
Explanation of responses
- F1The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.